Science News
from research organizations

AIDS Prevention Program Has Severe Shortcomings, Researchers Argue

Date:
November 23, 2007
Source:
BioMed Central
Summary:
South Africa's Prevention of Mother to Child Transmission Program has severe shortcomings that could be doing more harm than good. HIV patients are missing out on opportunities to receive a key intervention -- namely the nevirapine tablet -- according to a study published in AIDS Research and Therapy.
Share:
FULL STORY

South Africa's Prevention of Mother to Child Transmission (PMTCT) Programme has severe shortcomings that could be doing more harm than good. HIV patients are missing out on opportunities to receive a key intervention namely the nevirapine tablet according to a study published in the journal AIDS Research and Therapy.

The study's qualitative research with women who had participated in the public sector PMTCT programme revealed critical failures, not only in testing expectant mothers for HIV and giving them the results of the test, but also in a lack of intervention to help protect the unborn child from infection. A 50% reduction in transmission of HIV from mother to child is possible with the use of the drug, nevirapine, but this is not being administered routinely.

Lungiswa Nkonki, of the Medical Research Council, Tygerberg, South Africa, worked with colleagues from University of the Western Cape (UWC), Health Systems Trust and the Tulane School of Public Health and Tropical Medicine, New Orleans, USA, worked on the study.

The research team interviewed 58 HIV-positive women in South Africa and collected detailed information about their experiences of antenatal care. They also investigated whether or not there were missed opportunities for participation in prevention of mother-to-child transmission programs.

Fifteen of the interviewees missed out on nevirapine, not because of the stigma associated with HIV/AIDS, nor ignorance, but because of health systems failures, say the researchers. Of the 15 women, six women were not tested for HIV during antenatal care. Two who were tested received no results and seven were tested and received results but did not receive Nevirapine.

"Health Systems failures within these programme ranged from non-availability of counsellors, supplies such as HIV test kits, consent forms, health staff giving the women incorrect instructions about when to take the tablet and health staff not supplying the women with the tablet to take," the researchers say.

Nkonki and colleagues make two simple suggestions. First, HIV testing should be strengthened to enable access to preventative interventions. Secondly, a combination of two or three antiretroviral drugs starting during pregnancy and continuing for one week after delivery should replace the single dose regimen to improve uptake as recommended by the World Health Organisation (WHO).

Article: Lungiswa L Nkonki, Tanya M Doherty, Zelee Hill, Mickey Chopra, Nikki Schaay and Carl Kendall "Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake. A qualitative study." AIDS Research and Therapy (in press)


Story Source:

Materials provided by BioMed Central. Note: Content may be edited for style and length.


Cite This Page:

BioMed Central. "AIDS Prevention Program Has Severe Shortcomings, Researchers Argue." ScienceDaily. ScienceDaily, 23 November 2007. <www.sciencedaily.com/releases/2007/11/071121225010.htm>.
BioMed Central. (2007, November 23). AIDS Prevention Program Has Severe Shortcomings, Researchers Argue. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2007/11/071121225010.htm
BioMed Central. "AIDS Prevention Program Has Severe Shortcomings, Researchers Argue." ScienceDaily. www.sciencedaily.com/releases/2007/11/071121225010.htm (accessed May 23, 2017).

RELATED STORIES